| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bioethics, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.21 |
| 52 Week High | US$0.26 |
| 52 Week Low | US$0.21 |
| Beta | 0.72 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -95.88% |
| 5 Year Change | -94.75% |
| Change since IPO | -83.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| BOTH | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | -3.7% |
| 1Y | n/a | 22.5% | 20.2% |
Return vs Industry: Insufficient data to determine how BOTH performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how BOTH performed against the US Market.
Price Volatility
| BOTH volatility | |
|---|---|
| BOTH Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BOTH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BOTH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Mark Scharmann | n/a |
Bioethics, Ltd. does not have significant operations. It intends to seek, investigate, and acquire an interest in a business opportunity. The company was incorporated in 1990 and is headquartered in Ogden, Utah.
Bioethics, Ltd. Fundamentals Summary
| BOTH fundamental statistics | |
|---|---|
| Market cap | US$238.50k |
| Earnings (TTM) | -US$95.16k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.5x
P/E RatioIs BOTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOTH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$95.16k |
| Earnings | -US$95.16k |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -60.3% |
How did BOTH perform over the long term?
See historical performance and comparison